NCT02108158View on ClinicalTrials.gov

A Safety and Efficacy Study of Different Injections Volumes of Botulinum Toxin Type A, Azzalure, in the Glabellar Lines

PHASE4CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Glabellar Frown Lines
Interventions
DRUG

Azzalure

Trial Locations (2)

Unknown

Göteborgs Plastikkirurgiska Center, Gothenburg

Anna Neuromuskulär Konsult, Uppsala

Sponsors

Lead Sponsor

Galderma R&D
All Listed Sponsors
lead

Galderma R&D

INDUSTRY